1. Home
  2. SRPT vs HTH Comparison

SRPT vs HTH Comparison

Compare SRPT & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • HTH
  • Stock Information
  • Founded
  • SRPT 1980
  • HTH 1998
  • Country
  • SRPT United States
  • HTH United States
  • Employees
  • SRPT N/A
  • HTH N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • HTH Major Banks
  • Sector
  • SRPT Health Care
  • HTH Finance
  • Exchange
  • SRPT Nasdaq
  • HTH Nasdaq
  • Market Cap
  • SRPT 1.9B
  • HTH 2.1B
  • IPO Year
  • SRPT 1997
  • HTH 2004
  • Fundamental
  • Price
  • SRPT $23.53
  • HTH $32.43
  • Analyst Decision
  • SRPT Hold
  • HTH Hold
  • Analyst Count
  • SRPT 31
  • HTH 1
  • Target Price
  • SRPT $40.61
  • HTH $32.00
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • HTH 319.7K
  • Earning Date
  • SRPT 11-05-2025
  • HTH 10-23-2025
  • Dividend Yield
  • SRPT N/A
  • HTH 2.27%
  • EPS Growth
  • SRPT N/A
  • HTH 27.10
  • EPS
  • SRPT N/A
  • HTH 2.22
  • Revenue
  • SRPT $2,481,531,000.00
  • HTH $1,233,449,000.00
  • Revenue This Year
  • SRPT $9.41
  • HTH N/A
  • Revenue Next Year
  • SRPT N/A
  • HTH $0.66
  • P/E Ratio
  • SRPT N/A
  • HTH $14.32
  • Revenue Growth
  • SRPT 64.89
  • HTH 4.92
  • 52 Week Low
  • SRPT $10.42
  • HTH $26.67
  • 52 Week High
  • SRPT $138.81
  • HTH $36.14
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 62.36
  • HTH 45.63
  • Support Level
  • SRPT $21.93
  • HTH $30.78
  • Resistance Level
  • SRPT $23.87
  • HTH $33.38
  • Average True Range (ATR)
  • SRPT 1.42
  • HTH 0.79
  • MACD
  • SRPT 0.10
  • HTH -0.11
  • Stochastic Oscillator
  • SRPT 71.74
  • HTH 56.87

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

Share on Social Networks: